Loading quotes...

Forecast

The analysts' average price target is €12.08 (+10.62%). The median is €12.08 (+10.62%).

Buy
  5
Hold
  5
Sell
  1

  • Neogen rises after Piper Sandler upgrade and price-target increase

    Neogen's stock climbed about 3% in premarket trading after Piper Sandler raised its rating from "Neutral" to "Overweight" and lifted the price target from $13 to $14. The bank cited improved operational performance, accelerated growth in the food-safety segment, rising adjusted EBITDA margins, positive free cash flow and restored product availability. In the most recent fiscal fourth quarter, Neogen beat expectations on both adjusted EPS ($0.09) and revenue ($225.3 million) and issued a 2027 revenue forecast of $880–885 million, above analysts' estimates. » More on de.investing.com


  • Neogen reaches 52-week high of $11.45 after strong quarterly results

    Neogen shares rose to a new 52-week high of $11.45 and are currently trading at $11.46, giving the company a market capitalization of about $2.48 billion. Over the past year the stock gained roughly 100–144%, and year-to-date it is up about 34%. For the fourth quarter of fiscal 2026, Neogen reported adjusted earnings of $0.09 per share and revenue of $225.3 million, both above expectations, with organic growth of 4.3% (5.8% in the food safety segment). However, an InvestingPro valuation suggests the stock may be overvalued relative to its fair-value estimate. » More on de.investing.com


  • Neogen stock: investment from ten years ago would be about 54% less valuable

    On 18 June 2016 Neogen stock traded at USD 19.54; a USD 100 investment would have bought 5.118 shares at that time. At the last closing price of USD 8.93 that investment would be worth only USD 45.71, a decline of 54.29%. Neogen is most recently valued at around USD 2.02 billion; stock splits and dividends are not taken into account. » More on finanzen.net

Financials

In the last quarter, Neogen Co. had revenue of €191.78M and net profit of -€10.24M
(EUR) August 2026
YoY
Revenue 191.78M 7.18%
Gross profit 90.81M 11.79%
Net profit -10.24M 132.95%
EBITDA 24.1M 68.45%

Fundamentals

Metric Value
Market capitalization
€2.38B
Number of shares
218.31M
52-week high/low
€12.76 - €4.80
Dividends No
Beta
1.79
P/E ratio
-48.14
PEG ratio
0.03
P/B ratio
1.27
P/S ratio
3.01

Company profile

Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test for adenosine triphosphate, a chemical found in living cells. This segment offers its products primarily to food and feed processors; grain producers and processors; producers of cookies, crackers, candy, ice cream, and other processed foods; meat and poultry processors, seafood processors, fruit and vegetable producers, and dairies; laboratories; and producers of pharmaceuticals, cosmetics, veterinary vaccines, and nutraceutical products. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, diagnostic products, rodenticides, cleaners, disinfectants, insecticides, and genomics testing services for the animal safety market. This segment offers various products for researchers to detect biologically active substances. Its drug detection immunoassay test kits are used for the detection of abused and therapeutic drugs in farm and racing animals; detection of drug residues in meat and meat products; and human forensic toxicology drug screening applications. In addition, this segment's products are used to maintain sanitary conditions and limit the potential hazards of bacteria, fungi, and viruses. The company sells its products directly, as well as through distributors and retail chains. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.

Name
Neogen Co.
CEO
Mikhael Nassif
Headquarters Lansing, mi
USA
Website
Sector
Health Care
Industry
Biotechnology
IPO
08/23/1989
Employees 2,636

Ticker symbols

Exchange Symbol
NASDAQ
NEOG
Frankfurt
NG2.F
Düsseldorf
NG2.DU
🍪

Parqet  uses cookies. Learn more